Untargeted serum metabolomics reveals metabolic signatures distinguishing basal cell carcinoma risk groups: an exploratory analysis
These findings provide initial evidence that serum metabolomics can detect metabolic differences between LR and HR BCC and may serve as a basis for developing non-invasive biomarkers to improve BCC risk stratification.
Authors
- Carmen Socaciu (ORCID: https://orcid.org/0000-0002-7352-5057)
- Corina Bocşa (ORCID: https://orcid.org/0000-0002-6486-5981)
- Daniela Fodor (ORCID: https://orcid.org/0000-0003-3735-7970)
- Tudor Moisoiu (ORCID: https://orcid.org/0000-0002-9255-8217)
- Amalia Moisoiu
Institutions
- Technical University of Cluj-Napoca (RO)
- Iuliu Hațieganu University of Medicine and Pharmacy (RO)
- Clinical Emergency Hospital Bucharest (RO)
- County Hospital (GB)
- Romanian Academy (RO)
Publication Details
- Journal
- Medicine and Pharmacy Reports
- Published
- 2026-02-02
- DOI
- https://doi.org/10.15386/mpr-2961
- Primary Topic
- Metabolomics and Mass Spectrometry Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00